Vivakor (VIVK) Competitors $0.74 +0.05 (+6.68%) Closing price 08/28/2025 03:55 PM EasternExtended Trading$0.82 +0.07 (+9.99%) As of 04:02 AM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Competitors Stock AnalysisChartCompetitorsEarningsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestTrendsBuy This Stock VIVK vs. MXCT, SKLZ, HQI, VERI, ASPS, CTW, TDIC, AMWL, BAER, and TZUPShould you be buying Vivakor stock or one of its competitors? The main competitors of Vivakor include MaxCyte (MXCT), Skillz (SKLZ), HireQuest (HQI), Veritone (VERI), Altisource Portfolio Solutions (ASPS), CTW Cayman (CTW), Dreamland (TDIC), American Well (AMWL), Bridger Aerospace Group (BAER), and Thumzup Media (TZUP). These companies are all part of the "business services" industry. Vivakor vs. Its Competitors MaxCyte Skillz HireQuest Veritone Altisource Portfolio Solutions CTW Cayman Dreamland American Well Bridger Aerospace Group Thumzup Media MaxCyte (NASDAQ:MXCT) and Vivakor (NASDAQ:VIVK) are both small-cap business services companies, but which is the better stock? We will contrast the two businesses based on the strength of their analyst recommendations, media sentiment, risk, earnings, profitability, valuation, dividends and institutional ownership. Which has more volatility and risk, MXCT or VIVK? MaxCyte has a beta of 1.23, meaning that its stock price is 23% more volatile than the S&P 500. Comparatively, Vivakor has a beta of 1.07, meaning that its stock price is 7% more volatile than the S&P 500. Do insiders & institutionals hold more shares of MXCT or VIVK? 68.8% of MaxCyte shares are owned by institutional investors. Comparatively, 12.3% of Vivakor shares are owned by institutional investors. 3.3% of MaxCyte shares are owned by insiders. Comparatively, 44.5% of Vivakor shares are owned by insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a stock is poised for long-term growth. Do analysts recommend MXCT or VIVK? MaxCyte currently has a consensus price target of $7.00, suggesting a potential upside of 403.60%. Given MaxCyte's stronger consensus rating and higher probable upside, equities research analysts clearly believe MaxCyte is more favorable than Vivakor.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score MaxCyte 0 Sell rating(s) 2 Hold rating(s) 2 Buy rating(s) 0 Strong Buy rating(s) 2.50Vivakor 0 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 0.00 Is MXCT or VIVK more profitable? Vivakor has a net margin of -29.87% compared to MaxCyte's net margin of -125.22%. MaxCyte's return on equity of -22.12% beat Vivakor's return on equity.Company Net Margins Return on Equity Return on Assets MaxCyte-125.22% -22.12% -19.10% Vivakor -29.87%-31.68%-13.31% Which has better earnings & valuation, MXCT or VIVK? Vivakor has higher revenue and earnings than MaxCyte. MaxCyte is trading at a lower price-to-earnings ratio than Vivakor, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioMaxCyte$38.63M3.84-$41.06M-$0.43-3.23Vivakor$89.81M0.40-$22.19M-$1.09-0.68 Does the media prefer MXCT or VIVK? In the previous week, MaxCyte had 2 more articles in the media than Vivakor. MarketBeat recorded 3 mentions for MaxCyte and 1 mentions for Vivakor. Vivakor's average media sentiment score of 1.88 beat MaxCyte's score of 0.90 indicating that Vivakor is being referred to more favorably in the news media. Company Overall Sentiment MaxCyte Positive Vivakor Very Positive SummaryMaxCyte beats Vivakor on 9 of the 16 factors compared between the two stocks. Get Vivakor News Delivered to You Automatically Sign up to receive the latest news and ratings for VIVK and its competitors with MarketBeat's FREE daily newsletter. Subscribe Now View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding VIVK and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart VIVK vs. The Competition Export to ExcelMetricVivakorTechnology Services IndustryBusiness SectorNASDAQ ExchangeMarket Cap$33.54M$2.67B$26.17B$9.79BDividend YieldN/A1.58%2.78%4.02%P/E Ratio-0.6823.4328.1426.59Price / Sales0.4039.721,189.44155.76Price / CashN/A43.8626.8459.36Price / Book0.377.096.196.68Net Income-$22.19M$34.86M$197.87M$265.59M7 Day Performance-9.04%0.65%8.99%0.62%1 Month Performance-34.68%1.20%6.36%2.61%1 Year Performance-62.01%62.45%45.74%22.34% Vivakor Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)VIVKVivakor2.324 of 5 stars$0.74+6.7%N/A-62.0%$33.54M$89.81M-0.6820Positive NewsMXCTMaxCyte3.2454 of 5 stars$1.39-2.1%$7.00+403.6%-67.2%$151.38M$38.63M-3.2380SKLZSkillz2.6375 of 5 stars$8.65+0.8%$15.00+73.4%+51.7%$151.13M$95.47M-2.06650HQIHireQuest3.1498 of 5 stars$9.52-2.9%$13.00+36.6%-30.7%$138.18M$32.61M52.8965,000News CoverageAnalyst ForecastAnalyst RevisionVERIVeritone3.3006 of 5 stars$2.35-0.4%$4.50+91.5%-0.7%$130.44M$92.64M-2.83550ASPSAltisource Portfolio Solutions0.3412 of 5 stars$11.65+1.0%N/A+19.3%$126.79M$160.13M-2.671,160News CoveragePositive NewsCTWCTW CaymanN/A$2.17+8.0%N/AN/A$125.42MN/A0.00272News CoverageTDICDreamlandN/A$3.99+1.0%N/AN/A$118.50MN/A0.0015Positive NewsQuiet Period ExpirationAMWLAmerican Well2.9523 of 5 stars$6.98-2.4%$9.17+31.3%-12.0%$115.49M$269.78M-0.861,040BAERBridger Aerospace Group3.0664 of 5 stars$2.08+3.5%$5.25+152.4%-26.2%$111.61M$98.61M-3.59166Gap UpTZUPThumzup MediaN/A$5.53-7.8%N/AN/A$97.65MN/A-7.586 Related Companies and Tools Related Companies MaxCyte Alternatives Skillz Alternatives HireQuest Alternatives Veritone Alternatives Altisource Portfolio Solutions Alternatives CTW Cayman Alternatives Dreamland Alternatives American Well Alternatives Bridger Aerospace Group Alternatives Thumzup Media Alternatives Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:VIVK) was last updated on 8/29/2025 by MarketBeat.com Staff From Our PartnersMusk’s Project Colossus could mint millionairesI predict this single breakthrough could make Elon the world’s first trillionaire — and mint more new milliona...Brownstone Research | SponsoredINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | SponsoredBONUS GUIDE - Ben Stein Prepares For the Next Financial CrisisWith inflation high, debt soaring, and global tensions rising, a financial storm may be brewing. Economist ...Goldco Precious Metals | SponsoredThis is my Christian duty“This land I will give to you…” — a 4,000-year-old line from Genesis may hold the key to unlocking a $150 tril...Paradigm Press | SponsoredEveryone’s watching Nvidia right now. Here’s why I’m excited.So, unless you’ve been living under a rock, you probably saw the news… Nvidia just signed a $7 BILLION deal...Timothy Sykes | SponsoredAlex’s “Next Magnificent Seven” stocksThe original “Magnificent Seven” turned $7K into $1.18 million. Now, Alex Green has identified AI’s Next Ma...The Oxford Club | SponsoredElon’s Secret Social Security BombshellTo All Americans Born Before April 16th, 1963: Did Trump Just Give The Green Light To Radically RE-DO Social S...Banyan Hill Publishing | SponsoredOut of 18,347 Cryptocurrencies... This is the ONLY OneThe Single Most Undervalued DeFi Protocol You've Never Heard Of If there's one cryptocurrency you should b...Crypto 101 Media | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Vivakor, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Vivakor With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
MarketBeat All Access